• ECL Chemiluminescent Substrate Detection Kit Workflow

  2026-09-23

  Turn weak immunoblot bands into a more reliable quantitative workflow with extended signal duration, low background, and compatibility with diluted antibodies. This guide shows how to apply hypersensitive ECL to pathway validation, low-abundance targets, and follow-up experiments inspired by a recent Sanghuangporus vaninii study.

• Patient-Derived Gastric Cancer Assembloids

  2026-09-22

  Shapira-Netanelov and colleagues developed a patient-derived gastric cancer assembloid that combines matched tumor organoids with stromal subpopulations from the same tumor. The model reproduced tumor–stroma-dependent gene expression and drug-response differences, providing a more physiologically relevant platform for biomarker discovery, resistance studies, and personalized therapy screening.

• BMS-777607: From MET Biology to Translational Models

  2026-09-22

  BMS-777607 offers a defined way to interrogate MET-family signaling across cancer metastasis models and emerging hiPSC-derived platelet workflows. This thought-leadership guide connects kinase selectivity, experimental validation, formulation strategy, and translational decision-making without overstating preclinical evidence.

• Sildenafil Citrate: A Proteoform-Aware Strategy

  2026-09-21

  Sildenafil Citrate is more than a conventional PDE5 tool: it can connect cGMP biology, vascular phenotypes, ERK signaling, and proteoform-resolved drug interactions. This thought-leadership guide outlines how translational researchers can use the compound to distinguish biochemical potency from cellular mechanism, native-membrane selectivity, and disease-model relevance.

• Pyridostigmine Targets Placental Necroptosis in PE

  2026-09-21

  The reference study identifies placental necroptosis as a therapeutically relevant feature of preeclampsia-like disease and shows that pyridostigmine improves pathological responses in a rat reduced uterine perfusion pressure model. Its pharmacological and cell-based experiments implicate α7 nicotinic acetylcholine receptor signaling as a link between cholinergic activity, reduced placental inflammation, and improved trophoblast function.

• Carvacrol: Mechanisms, Uses, and Research Workflow

  2026-09-20

  Carvacrol, also called 5-isopropyl-2-methylphenol, is a monoterpene phenol used in antibacterial, redox, cell cycle, and apoptosis research. Product specifications define its identity, solvent compatibility, and cold-chain handling, while a 2026 Redox Biology study places carvacrol among non-electrophilic TRPA1 agonists that help distinguish singlet-oxygen signaling from hydrogen-peroxide signaling.

• Fusobacterium EVs Prepare Colorectal Cancer Niches

  2026-09-19

  Zheng et al. show that extracellular vesicles from Fusobacterium nucleatum are enriched in colorectal cancer and help create tumor-cell surfaces that support bacterial adhesion. Their in vivo, clinical, and mechanistic evidence identifies vesicle-delivered FomA and its interaction with FN1441 as a pathway linking bacterial dissemination with intratumoral colonization.

• Alda 1: An Assay-First Guide to ALDH2 Biology

  2026-09-18

  Alda 1 is an ALDH2 activator that connects aldehyde detoxification with cardiac stress, cardiomyocyte proliferation, and radiation injury models. This assay-first guide explains how to separate acute protection from regenerative signaling and design genotype-aware experiments.

• Mouse Neutrophil Cell Isolation Kit: Practical Guide

  2026-09-18

  Build faster, activation-conscious neutrophil workflows for bone marrow, blood, and spleen samples. This guide shows how negative selection supports high-purity functional assays, including emerging neutrophil-targeted nanovaccine studies, while offering practical optimization and troubleshooting advice.

• Imidazoline Antagonists and β-Cell K+ Channels

  2026-09-17

  Jonas, Plant, and Henquin showed that imidazoline α2-adrenoceptor antagonists stimulate insulin release mainly by inhibiting ATP-sensitive K+ channels in mouse pancreatic β-cells, not simply by blocking adrenoceptors. Their combination of 86Rb efflux, whole-cell patch clamp, and pharmacological rescue experiments offers a useful framework for separating receptor-mediated effects from direct ion-channel actions.

• G007-LK Tankyrase 1/2 Inhibitor Workflow

  2026-09-17

  G007-LK turns tankyrase biology into a practical assay strategy for Wnt/β-catenin, APC-mutant colorectal cancer, and Hippo–YAP research. This guide connects dose-response design with degradasome, reporter, protein, and proliferation readouts while highlighting formulation and troubleshooting choices.

• Annexin-V Maps Cardiomyocyte Death After I/R

  2026-09-16

  The reference study introduced labeled recombinant human annexin-V as an in vivo marker of phosphatidylserine exposure during myocardial ischemia and reperfusion. Its quantitative time-course data showed that cardiomyocyte death increased with reperfusion and ischemic duration, while pharmacological intervention markedly reduced annexin-V-positive cells.

• PPARG R212W in FPLD3: Mechanism and Evidence

  2026-09-16

  A 2026 study links the PPARG R212W variant to familial partial lipodystrophy type 3 through reduced receptor stability, impaired transcriptional activity, and mitochondrial bioenergetic dysfunction. Its partial rescue by Rosiglitazone supports residual ligand responsiveness as a mechanistic clue, while highlighting the need to distinguish cellular rescue from clinical efficacy.

• NLRP10 and Epidermal Homeostasis in Atopic Dermatitis

  2026-09-15

  The reference study identifies NLRP10 as a regulator of epidermal homeostasis that coordinates keratinocyte survival, p63-dependent differentiation, and barrier formation. Its combination of patient-skin analysis, human skin equivalents, and mechanistic studies connects reduced NLRP10 activity with defective barrier biology in atopic dermatitis and suggests a framework for evaluating NLRP10-linked therapeutic strategies.

• Acetylcysteine and the ROS–NF-κB Translation Gap

  2026-09-15

  Acetylcysteine, also known as N-acetyl-L-cysteine or NAC, is more than a generic antioxidant. Its cysteine-delivery, thiol-scavenging, and disulfide-reducing chemistry makes it a useful mechanistic probe for oxidative stress pathway modulation. This thought-leadership article connects NAC use in cochlear senescence research with practical assay design, translational model selection, and a more disciplined view of antioxidant evidence.

8348 records 1/557 page Next 12345 下5页 Last page